On 3 JUNE Yandex NV (NASDAQ:YNDX) announce that Yandex NV (NASDAQ:YNDX) has received approval for listing of its Class A shares (the “Shares”) in the Listing A Level 1, top quotation list on Moscow Exchange. Trading of Yandex Shares on Moscow Exchange is expected to commence on June 4, 2014 under symbol “YNDX”. Yandex NV (NASDAQ:YNDX) net profit margin is 32.40% and weekly performance is 2.87%. On last trading day company shares ended up $34.10. Analysts mean target price for the company is $1395.28. Yandex NV (NASDAQ:YNDX) distance from 50-day simple moving average (SMA50) is 14.97%.
Youku Tudou Inc (ADR) (NYSE:YOKU) reported ($0.14) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.20) by $0.06. The company had revenue of $112.70 million for the quarter. During the same quarter last year, the company posted ($0.23) earnings per share. Youku Tudou Inc’s revenue was up 36.0% compared to the same quarter last year. On average, analysts predict that Youku Tudou Inc will post $-1.65 earnings per share for the current fiscal year. Youku Tudou Inc (ADR) (NYSE:YOKU) shares fell -0.32% in last trading session and ended the day on $21.55. YOKU Gross Margin is 19.10% and its return on assets is -5.40%. Youku Tudou Inc (ADR) (NYSE:YOKU) quarterly performance is -26.10%.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ: PGNX) reported that the Anesthetic and Analgesic Drug Products Advisory Committee of the Food and Drug Administration (FDA) has provided an assessment of potential cardiovascular risk associated with products in the class of peripherally-active opioid receptor antagonists (PAMORAS) and recommendations regarding the necessity, timing, design and size of cardiovascular outcomes trials to support approval of products in this class for the proposed indication of opioid-induced constipation (OIC) in patients taking opioids for chronic pain. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) shares moved up 0.34% in last trading session and was closed at $113.80, while trading in range of $113.13 – $119.43. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) year to date (YTD) performance is 26.53%.
VIVUS, Inc. (NASDAQ:VVUS) announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis PLC, collectively referred to as Actavis. VIVUS, Inc. (NASDAQ:VVUS) ended the last trading day at $5.24. Company weekly volatility is calculated as 3.83% and price to cash ratio as 1.71. VIVUS, Inc. (NASDAQ:VVUS) showed a positive weekly performance of 2.95%.
On 14 MAY Tencent Holdings Ltd (OTCMKTS:TCTZD) said its first-quarter net profit rose 60% from a year earlier on improved revenue from online games. Tencent Holdings Ltd (OTCMKTS: TCTZD) on last trading day company shares ended up $14.75.